Skip to content
10-Q

Quarterly Report

GUARDION HEALTH SCIENCES, INC.

0001493152-24-031604

← back to feed
Filed
Aug 13, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Jul 31, 2024 1.28M sh
Shares Diluted Q2 2024 · Jun 30, 2024 1.3M sh
Shares Diluted Q2 2024 · Jun 30, 2024 1.29M sh
Shares Diluted restated Q2 2024 · Jun 30, 2023 1.27M sh
Shares Diluted restated Q2 2024 · Jun 30, 2023 1.27M sh
Operating Cash Flow Q2 2024 · Jun 30, 2024 −$1.83M
Operating Cash Flow Q2 2024 · Jun 30, 2023 −$2.29M
Cash And Equivalents Q2 2024 · Jun 30, 2024 $14.82M
Cash And Equivalents Q2 2024 · Dec 31, 2023 $6.36M
Stockholders Equity Q2 2024 · Jun 30, 2024 $13.75M
Stockholders Equity Q2 2024 · Mar 31, 2024 $3.41M
Stockholders Equity Q2 2024 · Dec 31, 2023 $8.15M
Stockholders Equity Q2 2024 · Jun 30, 2023 $7.24M
Stockholders Equity Q2 2024 · Mar 31, 2023 $8.48M
Stockholders Equity Q2 2024 · Dec 31, 2022 $7.92M
Current Liabilities Q2 2024 · Jun 30, 2024 $917.33K
Current Liabilities Q2 2024 · Dec 31, 2023 $1.32M
Total Liabilities Q2 2024 · Jun 30, 2024 $1.55M
Total Liabilities Q2 2024 · Dec 31, 2023 $3.77M
Current Assets Q2 2024 · Jun 30, 2024 $15.29M
Current Assets Q2 2024 · Dec 31, 2023 $11.88M
Total Assets Q2 2024 · Jun 30, 2024 $15.3M
Total Assets Q2 2024 · Dec 31, 2023 $11.92M
Eps Diluted Q2 2024 · Jun 30, 2024 $7.96
Eps Diluted Q2 2024 · Jun 30, 2024 $4.33
Eps Diluted restated Q2 2024 · Jun 30, 2023 −$0.92
Eps Diluted Q2 2024 · Jun 30, 2023 −$0.50
Eps Basic Q2 2024 · Jun 30, 2024 $8.04
Eps Basic Q2 2024 · Jun 30, 2024 $4.35
Eps Basic Q2 2024 · Jun 30, 2023 −$0.93
Eps Basic Q2 2024 · Jun 30, 2023 −$0.50
Sga Expense Q2 2024 · Jun 30, 2024 $1.4M
Sga Expense Q2 2024 · Jun 30, 2024 $2.83M
Sga Expense restated Q2 2024 · Jun 30, 2023 $1.41M
Sga Expense restated Q2 2024 · Jun 30, 2023 $3.11M
Net Income Q2 2024 · Jun 30, 2024 $10.32M
Net Income Q2 2024 · Jun 30, 2024 $5.58M
Net Income Q2 2024 · Mar 31, 2024 −$4.75M
Net Income Q2 2024 · Jun 30, 2023 −$1.17M
Net Income Q2 2024 · Jun 30, 2023 −$639.32K
Net Income Q2 2024 · Mar 31, 2023 $533.09K
Operating Income Q2 2024 · Jun 30, 2024 −$1.38M
Operating Income Q2 2024 · Jun 30, 2024 −$2.78M
Operating Income restated Q2 2024 · Jun 30, 2023 −$1.42M
Operating Income restated Q2 2024 · Jun 30, 2023 −$3.13M
Gross Profit Q2 2024 · Jun 30, 2024 $36.35K
Gross Profit Q2 2024 · Jun 30, 2024 $73.3K
Gross Profit restated Q2 2024 · Jun 30, 2023 −$6.94K
Gross Profit restated Q2 2024 · Jun 30, 2023 $18.74K
Cost Of Revenue Q2 2024 · Jun 30, 2024 $36.57K
Cost Of Revenue Q2 2024 · Jun 30, 2024 $80.74K
Cost Of Revenue restated Q2 2024 · Jun 30, 2023 $86.57K
Cost Of Revenue restated Q2 2024 · Jun 30, 2023 $155.13K
Revenue Q2 2024 · Jun 30, 2024 $72.92K
Revenue Q2 2024 · Jun 30, 2024 $154.04K
Revenue restated Q2 2024 · Jun 30, 2023 $79.63K
Revenue restated Q2 2024 · Jun 30, 2023 $173.87K
Capex Q2 2024 · Jun 30, 2023 $3.79K
Rd Expense restated Q2 2024 · Jun 30, 2023 $5.18K